Vergoeding 2020-2024 voor ATC-subgroep J05AB : Nucleosiden en nucleotiden (excl. reverse-transcr-remmers)
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| J05AB01 Aciclovir (Zovirax ®) | 435.240 | 325.390 | 288.750 | 298.830 | 279.500 |
| J05AB06 Ganciclovir (Cymevene ®) | 165 | 30 | 678 | . | . |
| J05AB09 Famciclovir | 1.631.400 | 955.150 | 927.400 | 1.564.300 | 1.549.400 |
| J05AB11 Valaciclovir (Zelitrex ®) | 3.088.300 | 2.727.300 | 2.719.000 | 4.709.600 | 7.207.200 |
| J05AB14 Valganciclovir (Valcyte ®) | 745.820 | 675.600 | 771.330 | 912.630 | 1.001.400 |
| Totaal | 5.900.925 | 4.683.470 | 4.707.158 | 7.485.360 | 10.037.500 |